How much profit has Biophytis made this year?
Biophytis has made -12.17 M EUR this year.
Biophytis Net Income 2024
Biophytis Net Income
-12.17 M EUR
Ticker
ALBPS.PA
ISIN
FR0012816825
WKN
A14V4J
In 2024, Biophytis's profit amounted to -12.17 M EUR, a -28.54% increase from the -17.03 M EUR profit recorded in the previous year.
The Biophytis Net Income history
| YEAR | NET INCOME (undefined EUR) |
|---|---|
| 2026e | 297.42 |
| 2025e | -16,384.93 |
| 2024e | -12,167.03 |
| 2023 | -17,026 |
| 2022 | -24,216 |
| 2021 | -31,164 |
| 2020 | -25,517 |
| 2019 | -17,788 |
| 2018 | -13,987 |
| 2017 | -11,409 |
| 2016 | -7,954 |
| 2015 | -5,232 |
| 2014 | -710 |
| 2013 | -520 |
Biophytis Revenue, EBIT, Net Income FR0012816825 · A14V4J
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Biophytis, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Biophytis from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Biophytis’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Biophytis. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Biophytis’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Biophytis’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Biophytis’s growth potential.
Biophytis Revenue, EBIT and net profit per share
| Date | Biophytis Revenue | Biophytis EBIT | Biophytis Net Income |
|---|---|---|---|
| 2026e | 22.15 M undefined | -6.18 M undefined | 297,416.15 undefined |
| 2025e | 2.58 M undefined | -6.18 M undefined | -16.38 M undefined |
| 2024e | 6.18 M undefined | 5.15 M undefined | -12.17 M undefined |
| 2023 | 0 undefined | -14.33 M undefined | -17.03 M undefined |
| 2022 | 0 undefined | -23.27 M undefined | -24.22 M undefined |
| 2021 | 0 undefined | -26.82 M undefined | -31.16 M undefined |
| 2020 | 0 undefined | -13.94 M undefined | -25.52 M undefined |
| 2019 | 0 undefined | -15.68 M undefined | -17.79 M undefined |
| 2018 | 0 undefined | -13.86 M undefined | -13.99 M undefined |
| 2017 | 0 undefined | -9.91 M undefined | -11.41 M undefined |
| 2016 | 0 undefined | -7.94 M undefined | -7.95 M undefined |
| 2015 | 0 undefined | -5.04 M undefined | -5.23 M undefined |
| 2014 | 0 undefined | -670,000 undefined | -710,000 undefined |
| 2013 | 0 undefined | -500,000 undefined | -520,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2013 | 0 EUR | -500,000 EUR | -520,000 EUR |
| 2014 | 0 EUR | -670,000 EUR | -710,000 EUR |
| 2015 | 0 EUR | -5.04 M EUR | -5.23 M EUR |
| 2016 | 0 EUR | -7.94 M EUR | -7.95 M EUR |
| 2017 | 0 EUR | -9.91 M EUR | -11.41 M EUR |
| 2018 | 0 EUR | -13.86 M EUR | -13.99 M EUR |
| 2019 | 0 EUR | -15.68 M EUR | -17.79 M EUR |
| 2020 | 0 EUR | -13.94 M EUR | -25.52 M EUR |
| 2021 | 0 EUR | -26.82 M EUR | -31.16 M EUR |
| 2022 | 0 EUR | -23.27 M EUR | -24.22 M EUR |
| 2023 | 0 EUR | -14.33 M EUR | -17.03 M EUR |
| 2024e | 6.18 M EUR | 5.15 M EUR | -12.17 M EUR |
| 2025e | 2.58 M EUR | -6.18 M EUR | -16.38 M EUR |
| 2026e | 22.15 M EUR | -6.18 M EUR | 297,416.15 EUR |
Biophytis stock margins FR0012816825 · A14V4J
The Biophytis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biophytis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biophytis.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Biophytis's sales revenue. A higher gross margin percentage indicates that the Biophytis retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Biophytis's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Biophytis's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Biophytis's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Biophytis. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Biophytis's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Biophytis Margin History
| Biophytis Gross margin | Biophytis Profit margin | Biophytis EBIT margin | Biophytis Profit margin |
|---|---|---|---|
| 2026e | 0 % | -27.91 % | 1.34 % |
| 2025e | 0 % | -240 % | -636.31 % |
| 2024e | 0 % | 83.33 % | -196.88 % |
| 2023 | 0 % | 0 % | 0 % |
| 2022 | 0 % | 0 % | 0 % |
| 2021 | 0 % | 0 % | 0 % |
| 2020 | 0 % | 0 % | 0 % |
| 2019 | 0 % | 0 % | 0 % |
| 2018 | 0 % | 0 % | 0 % |
| 2017 | 0 % | 0 % | 0 % |
| 2016 | 0 % | 0 % | 0 % |
| 2015 | 0 % | 0 % | 0 % |
| 2014 | 0 % | 0 % | 0 % |
| 2013 | 0 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2013 | 0 % | 0 % | 0 % |
| 2014 | 0 % | 0 % | 0 % |
| 2015 | 0 % | 0 % | 0 % |
| 2016 | 0 % | 0 % | 0 % |
| 2017 | 0 % | 0 % | 0 % |
| 2018 | 0 % | 0 % | 0 % |
| 2019 | 0 % | 0 % | 0 % |
| 2020 | 0 % | 0 % | 0 % |
| 2021 | 0 % | 0 % | 0 % |
| 2022 | 0 % | 0 % | 0 % |
| 2023 | 0 % | 0 % | 0 % |
| 2024e | 0 % | 83.33 % | -196.88 % |
| 2025e | 0 % | -240 % | -636.31 % |
| 2026e | 0 % | -27.91 % | 1.34 % |
Biophytis Aktienanalyse
What does Biophytis do?
Biophytis SA is a pharmaceutical company specializing in the development of therapies for age-related diseases such as muscle wasting and other neurodegenerative diseases. The company focuses on developing medications with natural ingredients that aim to improve physical performance and metabolic processes in older adults. Biophytis SA's business model is based on researching and developing innovative therapies for age-related diseases, using advanced technologies and research methods. The company has expanded its focus to include therapies for neurodegenerative diseases like Alzheimer's and Parkinson's. Biophytis SA is divided into two main divisions: the biomedical division, which focuses on developing medications based on natural plant compounds to combat age-related muscle wasting and improve physical performance, and the biometric division, which focuses on using big data and statistical analysis in medical research studies. The company's portfolio includes the drug Sarconeos, which is designed to improve physical performance and reduce muscle wasting in older adults. Biophytis SA aims to improve global healthcare by developing therapies for age-related diseases, utilizing advanced research methods and big data to improve statistical analysis and study. The company collaborates with prestigious partners and research institutions to achieve the goal of enabling older adults to live healthier lives. Biophytis ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Biophytis's Profit Margins
The profit margins of Biophytis represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Biophytis's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Biophytis's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Biophytis's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Biophytis’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Biophytis stock
How has the profit developed compared to last year?
The profit has increased by -28.54% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Biophytis publish its earnings?
Biophytis publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Biophytis?
The profits of Biophytis are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Biophytis?
You can learn more about the earnings of Biophytis by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Biophytis pay?
Over the past 12 months, Biophytis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biophytis is expected to pay a dividend of 0 EUR.
What is the dividend yield of Biophytis?
The current dividend yield of Biophytis is .
When does Biophytis pay dividends?
Biophytis pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biophytis?
Biophytis paid dividends every year for the past 0 years.
What is the dividend of Biophytis?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biophytis located?
Biophytis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biophytis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biophytis from 11/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/29/2024.
When did Biophytis pay the last dividend?
The last dividend was paid out on 11/29/2024.
What was the dividend of Biophytis in the year 2023?
In the year 2023, Biophytis distributed 0 EUR as dividends.
In which currency does Biophytis pay out the dividend?
The dividends of Biophytis are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biophytis
Our stock analysis for Biophytis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biophytis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
